137 related articles for article (PubMed ID: 18668352)
1. Manipulation of corticosteroid release from a transiently supersaturated topical metered dose aerosol using a residual miscible co-solvent.
Reid ML; Brown MB; Jones SA
Pharm Res; 2008 Nov; 25(11):2573-80. PubMed ID: 18668352
[TBL] [Abstract][Full Text] [Related]
2. Transient drug supersaturation kinetics of beclomethasone dipropionate in rapidly drying films.
Reid ML; Jones SA; Brown MB
Int J Pharm; 2009 Apr; 371(1-2):114-9. PubMed ID: 19150492
[TBL] [Abstract][Full Text] [Related]
3. Determining degree of saturation after application of transiently supersaturated metered dose aerosols for topical delivery of corticosteroids.
Jones SA; Reid ML; Brown MB
J Pharm Sci; 2009 Feb; 98(2):543-54. PubMed ID: 18548616
[TBL] [Abstract][Full Text] [Related]
4. Topical corticosteroid delivery into human skin using hydrofluoroalkane metered dose aerosol sprays.
Reid ML; Benaouda F; Khengar R; Jones SA; Brown MB
Int J Pharm; 2013 Aug; 452(1-2):157-65. PubMed ID: 23684656
[TBL] [Abstract][Full Text] [Related]
5. Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers.
Buttini F; Miozzi M; Balducci AG; Royall PG; Brambilla G; Colombo P; Bettini R; Forbes B
Int J Pharm; 2014 Apr; 465(1-2):42-51. PubMed ID: 24491530
[TBL] [Abstract][Full Text] [Related]
6. Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient.
Lewis DA; Young PM; Buttini F; Church T; Colombo P; Forbes B; Haghi M; Johnson R; O'Shea H; Salama R; Traini D
Eur J Pharm Biopharm; 2014 Jan; 86(1):31-7. PubMed ID: 23523547
[TBL] [Abstract][Full Text] [Related]
7. Humidity affects the morphology of particles emitted from beclomethasone dipropionate pressurized metered dose inhalers.
Ivey JW; Bhambri P; Church TK; Lewis DA; McDermott MT; Elbayomy S; Finlay WH; Vehring R
Int J Pharm; 2017 Mar; 520(1-2):207-215. PubMed ID: 28167262
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of beclomethasone-hydrofluoroalkane interactions using biocompatible macromolecules.
Jones SA; Martin GP; Brown MB
J Pharm Sci; 2006 May; 95(5):1060-74. PubMed ID: 16552748
[TBL] [Abstract][Full Text] [Related]
9. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.
Shemirani FM; Hoe S; Lewis D; Church T; Vehring R; Finlay WH
J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):215-22. PubMed ID: 23094687
[TBL] [Abstract][Full Text] [Related]
10. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
11. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers.
Gupta A; Stein SW; Myrdal PB
J Aerosol Med; 2003; 16(2):167-74. PubMed ID: 12823910
[TBL] [Abstract][Full Text] [Related]
12. Metered-dose inhaler formulations with beclomethasone-17,21-dipropionate using the ozone friendly propellant R 134a.
Steckel H; Müller BW
Eur J Pharm Biopharm; 1998 Jul; 46(1):77-83. PubMed ID: 9700025
[TBL] [Abstract][Full Text] [Related]
13. The effect of actuator nozzle designs on the electrostatic charge generated in pressurised metered dose inhaler aerosols.
Chen Y; Young PM; Fletcher DF; Chan HK; Long E; Lewis D; Church T; Traini D
Pharm Res; 2015 Apr; 32(4):1237-48. PubMed ID: 25270573
[TBL] [Abstract][Full Text] [Related]
14. Towards the bioequivalence of pressurised metered dose inhalers 2. Aerodynamically equivalent particles (with and without glycerol) exhibit different biopharmaceutical profiles in vitro.
Haghi M; Bebawy M; Colombo P; Forbes B; Lewis DA; Salama R; Traini D; Young PM
Eur J Pharm Biopharm; 2014 Jan; 86(1):38-45. PubMed ID: 23528797
[TBL] [Abstract][Full Text] [Related]
15. How to engineer aerosol particle properties and biopharmaceutical performance of propellant inhalers.
Akhuemokhan P; Green NA; Haddrell A; Lewis D; Reid JP; Forbes B
Int J Pharm; 2023 Mar; 634():122676. PubMed ID: 36738807
[TBL] [Abstract][Full Text] [Related]
16. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
Davies RJ; Stampone P; O'Connor BJ
Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
[TBL] [Abstract][Full Text] [Related]
17. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
Gross G; Thompson PJ; Chervinsky P; Vanden Burgt J
Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
[TBL] [Abstract][Full Text] [Related]
18. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
Zhu B; Traini D; Chan HK; Young PM
Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
[TBL] [Abstract][Full Text] [Related]
19. Isothermal calorimetry: a predictive tool to model drug-propellant interactions in pressurized metered dose systems.
Ooi J; Gaisford S; Boyd BJ; Young PM; Traini D
Int J Pharm; 2014 Jan; 461(1-2):301-9. PubMed ID: 24325938
[TBL] [Abstract][Full Text] [Related]
20. In vitro performance of two common valved holding chambers with a chlorofluorocarbon-free beclomethasone metered-dose inhaler.
Asmus MJ; Coowanitwong I; Kwon SH; Khorsand N; Hochhaus G
Pharmacotherapy; 2003 Dec; 23(12):1538-44. PubMed ID: 14695033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]